Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Apr 09, 2020

SELL
$3.49 - $9.2 $1.37 Million - $3.6 Million
-391,607 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$6.27 - $11.41 $794,051 - $1.44 Million
-126,643 Reduced 24.44%
391,607 $3.61 Million
Q3 2019

Nov 14, 2019

BUY
$4.75 - $8.38 $2.46 Million - $4.34 Million
518,250 New
518,250 $3.63 Million

Others Institutions Holding OPTN

About OptiNose, Inc.


  • Ticker OPTN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 83,277,504
  • Market Cap $40M
  • Description
  • OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...
More about OPTN
Track This Portfolio

Track Wildcat Capital Management, LLC Portfolio

Follow Wildcat Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wildcat Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wildcat Capital Management, LLC with notifications on news.